NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024
Journal of the National Comprehensive Cancer Network · 2024-10 · 22 (8) · 512-519
DOI: 10.6004/jnccn.2024.0052 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-10. Verfasst von Joyce Liu und 39 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber/Brigham and Women's Cancer Center. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms. Die Arbeit wurde bisher 150-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dana-Farber/Brigham and Women's Cancer Center.
- Duke Cancer Institute.
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
- City of Hope National Medical Center.
- Memorial Sloan Kettering Cancer Center.
- O'Neal Comprehensive Cancer Center at UAB.
Zitieren
APA
Liu, J., Berchuck, A., Backes, F. J., Cohen, J., Grisham, R., Leath, C. A., Martin, L., Matei, D., Miller, D. S., Robertson, S., Barroilhet, L., Uppal, S., Hendrickson, A. W., Gershenson, D. M., Gray, H. J., Hakam, A., Jain, A., Konecny, G. E., Moroney, J., …, & Armstrong, D. K. (2024). NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. Journal of the National Comprehensive Cancer Network, 22(8), 512-519. https://doi.org/10.6004/jnccn.2024.0052
Vancouver
Liu J, Berchuck A, Backes FJ, Cohen J, Grisham R, Leath CA, et al. NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. Journal of the National Comprehensive Cancer Network. 2024;22(8):512-519. doi:10.6004/jnccn.2024.0052
BibTeX
@article{Liu2024,
author = {Liu, Joyce and Berchuck, Andrew and Backes, Floor J and Cohen, Joshua and Grisham, Rachel and Leath, Charles A and Martin, Lainie and Matei, Daniela and Miller, David S and Robertson, Sharon and Barroilhet, Lisa and Uppal, Shitanshu and Hendrickson, Andrea Wahner and Gershenson, David M and Gray, Heidi J and Hakam, Ardeshir and Jain, Angela and Konecny, Gottfried E and Moroney, John and Ratner, Elena and Schorge, John and Thaker, Premal H and Werner, Theresa L and Zsiros, Emese and Behbakht, Kian and Chen, Lee-May and DeRosa, Marie and Eisenhauer, Eric L and Leiserowitz, Gary and Litkouhi, Babak and McHale, Michael and Percac-Lima, Sanja and Rodabaugh, Kerry and Vargas, Roberto and Jones, Frankie and Kovach, Emily and Hang, Lisa and Ramakrishnan, Swathi and Alvarez, Ronald D and Armstrong, Deborah K},
title = {NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
volume = {22},
number = {8},
pages = {512--519},
doi = {10.6004/jnccn.2024.0052}
}
EUVIMED